Late-onset riboflavin transporter deficiency: a treatable mimic of various motor neuropathy aetiologies.


Journal

Journal of neurology, neurosurgery, and psychiatry
ISSN: 1468-330X
Titre abrégé: J Neurol Neurosurg Psychiatry
Pays: England
ID NLM: 2985191R

Informations de publication

Date de publication:
21 Oct 2020
Historique:
received: 02 04 2020
revised: 27 07 2020
accepted: 18 08 2020
entrez: 22 10 2020
pubmed: 23 10 2020
medline: 23 10 2020
Statut: aheadofprint

Résumé

Riboflavin transporter deficiencies (RTDs), involving We retrospectively collected clinical, biological and electrophysiological data from all French RTD patients with MN onset after 10 years of age (n=6) and extracted data from 19 other similar RTD patients from the literature. Adult RTD patients with MN had heterogeneous clinical presentations, potentially mimicking amyotrophic lateral sclerosis or distal hereditary motor neuropathy (56%), multinevritis with cranial nerve involvement (16%), Guillain-Barré syndrome (8%) and mixed motor and sensory neuronopathy syndromes (20%, only in Whereas late-onset RTD may mimic different acquired or genetic causes of motor neuropathies, it is a diagnosis not to be missed since high-dose riboflavin per oral supplementation is often highly efficient.

Identifiants

pubmed: 33087424
pii: jnnp-2020-323304
doi: 10.1136/jnnp-2020-323304
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: YN received speech honoraria from Actelion and Orphan Europe, and received travel funding from Actelion, Shire and Genzyme.

Auteurs

Christophe Carreau (C)

Department of Neurology, Reference Center for Lysosomal Diseases, Neuro-Metabolism Unit, AP-HP, Hôpital Universitaire Pitié Salpêtrière, Paris, France.

Charline Benoit (C)

Department of Neurology, AP-HP, Hôpital Universitaire Pitié Salpêtrière, Paris, France.

Guido Ahle (G)

Neurology, Hôpital Louis Pasteur, Colmar, Alsace, France.

Cécile Cauquil (C)

Neurology, Hôpital Bicêtre, Le Kremlin-Bicêtre, Île-de-France, France.

Agathe Roubertie (A)

Neuropediatrie, Hôpital Gui de Chauliac Pôle Neurosciences tête et cou, Montpellier, Languedoc-Roussillon Midi, France.

Timothée Lenglet (T)

Department of Neurophysiology, AP-HP, Hôpital Universitaire Pitié Salpêtrière, Paris, France.

Jeremy Cosgrove (J)

Neurology, Leeds Teaching Hospitals NHS Trust, Leeds, UK.

Isabelle Meunier (I)

Ophthalmology, Hôpital Gui de Chauliac, Montpellier, Languedoc-Roussillon, France.

Alice Veauville-Merllié (A)

Laboratory of Inborn Errors of Metabolism, Hospices Civils de Lyon, Lyon, Auvergne-Rhône-Alpes, France.

Cécile Acquaviva-Bourdain (C)

Laboratory of Inborn Errors of Metabolism, Hospices Civils de Lyon, Lyon, Auvergne-Rhône-Alpes, France.

Yann Nadjar (Y)

Department of Neurology, Reference Center for Lysosomal Diseases, Neuro-Metabolism Unit, AP-HP, Hôpital Universitaire Pitié Salpêtrière, Paris, France yann.nadjar@aphp.fr.

Classifications MeSH